Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Sagimet Biosciences (SGMT) Leases (2022 - 2026)

Sagimet Biosciences' Leases history spans 5 years, with the latest figure at $39000.0 for Q1 2026.

  • Quarterly Leases rose 2.63% to $39000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $39000.0 through Mar 2026, up 2.63% year-over-year, with the annual reading at $78000.0 for FY2025, 1.3% up from the prior year.
  • Leases came in at $39000.0 for Q1 2026, down from $78000.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $212000.0 in Q4 2022 to a low of $37000.0 in Q1 2024.
  • The 5-year median for Leases is $109000.0 (2023), against an average of $103000.0.
  • Year-over-year, Leases plummeted 65.57% in 2023 and then increased 5.48% in 2024.
  • Sagimet Biosciences' Leases stood at $212000.0 in 2022, then tumbled by 65.57% to $73000.0 in 2023, then rose by 5.48% to $77000.0 in 2024, then grew by 1.3% to $78000.0 in 2025, then plummeted by 50.0% to $39000.0 in 2026.
  • Per Business Quant, the three most recent readings for SGMT's Leases are $39000.0 (Q1 2026), $78000.0 (Q4 2025), and $115000.0 (Q3 2025).